1. Home
  2. MIR vs STVN Comparison

MIR vs STVN Comparison

Compare MIR & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirion Technologies Inc.

MIR

Mirion Technologies Inc.

HOLD

Current Price

$22.31

Market Cap

6.2B

Sector

Technology

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$16.03

Market Cap

5.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIR
STVN
Founded
2005
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.4B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MIR
STVN
Price
$22.31
$16.03
Analyst Decision
Strong Buy
Hold
Analyst Count
8
2
Target Price
$28.38
$23.75
AVG Volume (30 Days)
3.2M
1.0M
Earning Date
02-10-2026
03-05-2026
Dividend Yield
N/A
0.41%
EPS Growth
N/A
19.61
EPS
0.11
0.60
Revenue
$925,400,000.00
$1,373,219,524.00
Revenue This Year
$24.27
$8.42
Revenue Next Year
$7.48
$9.61
P/E Ratio
$204.64
$26.78
Revenue Growth
7.50
6.97
52 Week Low
$12.00
$13.91
52 Week High
$30.28
$28.00

Technical Indicators

Market Signals
Indicator
MIR
STVN
Relative Strength Index (RSI) 32.13 39.17
Support Level $20.84 $15.06
Resistance Level $24.30 $16.69
Average True Range (ATR) 1.15 1.03
MACD -0.46 0.13
Stochastic Oscillator 11.80 43.54

Price Performance

Historical Comparison
MIR
STVN

About MIR Mirion Technologies Inc.

Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: